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resistant mutant viruses. Only in 4 cases out of 13 with positive p24 antigen
any genotypic resistance mutation was detected.
Conclusions: in spite of low HIV-l RNA levels in plasma which would
indicate a good response to treatment, the presence of viral strains harbour-
ing nucleoside analogue mutations together with a positive HIVp24 antigen
suggest that the infective capacity persists in these patients. Further studies
are needed to evaluate a possible rebound viral load in these cases.
IMoP111 Maternal zidovudine prophylaxis and HIV-1 vertical
transmission
G. V. Zuccotti, E. D'Auria, C. Cucchi, L. Tegaldo, M. Giovannini
Department ofPaediatrics, San Paolo Hospital, Milan, Italy
ObjectIve: Toa~s the role ofthe maternal zidovudine (ZDV) prophylaxis
in the prevention of mother-to-infant transmission of human immunode-
ficiency virus type 1 (HIV-I).
Methods: Fourty-seven HIV-infected mothers and their infants, born
between January 1997 and August 1999 in our Department, were enrolled
in this prospective study.
All the mothers were given ZDV during pregnancy, according to ACTG
076 regimen. Of the 47 treated women, 37 (78.7%) received ZDV alone
(group A) while the remaining (21.3%) received ZDV plus one or two other
antiretroviral drugs (group B). None of the infants received ZDV prophy-
laxis or other antiretroviral treatments. All infants were formula-fed.
The percentage ofelective caesarean section was respectively 75% in the
group A and 100% in the group B (p = 0.18, Fisher's exact test).
Results: The mother-to-infant transmission rate was 2.7% (95% CI,
1.8%-3.5%) in the group A. No HIV infected infants were observed in
the group B.
Conclusions: These findings suggest that maternal ZDV prophylactic treat-
ment alone may be enough to prevent HIV-I vertical transmission.
IMoP12! Comparison between An monotherapy and
combination antiretroviral regimen: safety and ecacy in
preventing HIV vertical transmission
A. Maccabrunil,l. Pacatil , M. F. Ravagni2, G. Michelone', M. Furione3,
M. Gatti4
IInstitute of Infectious Diseases; 2Dept. ofObstetrics and Gynecology; JInfectiuos
Diseases Research Laboratory; 4Virology Service Pavia, Italy
Objectives: The majority ofseropositive women maintain or begin during
pregnancy the optimal antiretroviral combination regimen for their own
health; only in a few cases monotherapy with AZT, still represents the best
preventive strategy. Aim of our study is to better evaluate the efficacy and
safety of the highly active antiretroviral therapy in comparison with AZT
alone in women and newborns.
Methods: During the years 1997-1999 we followed 44 HIV-infected
pregnant women. 25 of them were treated with AZT alone from the 14'
week of pregnancy. 19 (6 of whom still in pregnancy) received double
NRTI therapy with (8 cases) or without (II cases) one PI. Elective caesarean
delivery has been performed in 17/25 cases in the first group and in 8/12 in
the second group ofwomen. 27/37 newborns received AZT during the first
6 weeks of life.
Results: The main adverse effect of the therapy was anaemia, observed in 71
25 women in the 1st group, in 5/8 women (in double therapy with AZT) in
the 2nd and in 8/27 neonates. No teratogenic effects were found in the
neonates exposed to antiviral drugs from the first trimester of pregnancy.
One baby in the 1st group resulted HIV-infected; no cases of transmission
were observed in the second group.
Conclusion: Our data confirm the role ofhighly active therapy with elective
caesarean delivery in preventing the risk of perinatal HIV infection.
Although we couldn't fmd any severe adverse effect in women or in
newborns, more prolonged studies to assess the safety of combination
regimens are mandatory.
[MOP13J Degradation of 3'azido-3'deoxythymidine (AZT) by
Stenotrophomonas mahophila and other bacteria
H. Kruszewska', U. Chmielowiec2, A. Lipkowske, S. Tyski l
1Drug Institute; 2Pharmaceutical Research Institute; J Institute of Industrial
Chemistry, Warsaw, Poland
Stenotrophomonas maltophila may be etiological agent of sepsis, pneumonia
and urinary tract infections of patients with AIDS. Since the deoxythymi-
dine derivative - 3'azido-3'deoxythymidine (AZT) is still used in the
treatment of AIDS, it was interesting to investigate whether some bacterial
strains are able to degrade AZT at concentration used in the therapy.
It was found that S. maltophila (Wrodaw Culture Collection - PCM 2381)
can degrade AZT at concentration 500 J.tg/ml, which did not influence
bacterial growth. On the contrary, E. coli (ATCC 8739), Lactobaci1lus
acidophilus (Biomed, Krakow Culture Collection), P. aeruginosa (ATCC
15442) were not able to degrade AZT, however this drug at concentration
500 J.tg/ml did not inhibit bacterial growth during 140 h of incubation.
Surprisingly, all but L. acidophilus strains were able to degrade egzogenic
deoxythymidine monophosphate (dTMP). Stenotrophomonas maltophila and
P. aeruginosa hydrolysed deoxythymidine monophosphate to deoxythymi-
dine and than to thymine, whereas in case of E. coli, a considerable
accumulation of deoxythymidine was observed in the end of dTMP
hydrolysis, what indicate different mechanism of this degradation.
This study indicate that S. maltophila infections may lead to decrease the
efficiency of AZT treatment in AIDS patients.
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IMoP141 Subtyplng of HIV-1 in IDUs in Russia: Evidence of
subtype homogeneity at the main sites of the epidemic
E. Kazennova1, M. Bobkova2, L. Selimova', V. Pokrovsk/,J. WeberJ ,
A. Bobkovl
tIvanovsky Institute of Virology; 2Federal AIDS Centre, Moscow, Russian
Federation; JImperial College School ofMedicine, London, United Kingdom
Objectives: Previously we have demonstrated the existence of three HIV-l
variants responsible for the explosive epidemic among IOUs in the former
USSR. To develop a V3-PEIA for subtyping of HIV-1 sera derived from
IDUs. To determine current proportions of infections due to env genetic
subtypes A and B or AlB recombinants at the main sites of the epidemic in
Russia.
Methods: Two synthetic peptides, PI and P2 (Cheingsong-Popov et al.
1994), were evaluated in an PEIA on 63 HIV-1 IOUs sera for which
genotypes had been determined by sequencing. The sensitivities of PI
(subtype B) and P2 (subtype A) were 87% and 75%, respectively. Specificity
of the assay was 100% for both peptides, with 100% predictive values of a
monoreactive positive test for both peptides.
Results: We have serotyped 401/5561DUs sera in five territories. In Tver'
(n = 345), Nizhniy Novgorod (n = 61), and Rostov-on-Don (n = 72)
regions, and Krasnodar Kray (n = 32) 100% of typable sera were found to
belong to env subtype A. All specimens subtyped in Kaliningrad region (n =
46) belonged to etIV subtype B. However, nucleotide sequencing of the gag
p17-p24 encoding region showed that all 17 independently obtained speci-
mens from Kaliningrad region had gagA genotype and, thus, were recom-
binants.
Conduslons: The results demonstrated a high level ofsubtype homogeneity
at the main sites of the epidemic in Russia. HIV-I genetic subtype A
predominates nowadays. At present time another parental gagBenvB strain
is of minor importance in the rDUs epidemic.
IMoP1S1 HIV subtype distribution in Southern Spain
M. Alvarez, F. Garcia, A. Reyes', N. M. Martinez, P. Morata, M. C.
Bernal, F. Garcia]r.,). Hernandez, G. Piedrola, M. C. Maroto
Microbiology and 1. Diseases Units, Universitary Hospital, Granada; IHospital
Torrecardetlas, Almeria, Spain
objective: to evaluate the introduction of subtypes other than B in the
population from Southern Spain.
Patients and Methods: 83 patients infected before 1996 (group I), 14
patients infected after 1996 (group 2) and 15 African immigrants living in
the coast of Almeria (group 3) were studied. Molecular subtyping was by
Heteroduplex Mobility Assay with 700 bp amplificates from the V3-V5
loop ofgp120 of:lCrum RNAurPBMC DNA (when viralluaJ was -<: 1000
copies/ml) and amplificates from reference subtypes (A to H) from NIH
AIDS Reagent Program. PAGE and silver staining was used to evaluate
heteroduplex formation.
Results: Subtype B was at 79/83 (95%) from group I (before 1996), at 12/14
(85%) from group 2 (after 1996), and at 7/15 (47%) African immigrants.
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Subtype A was at 3 patients from group I, 2 from group 2 and 7 from group
3.
Conclusion: Non B subtypes are not present so far at the recently infected
HIV patients from Southern Spain. However, other subtypes, are present at
our geographical area though to the present only in foreign patients.
IMOP161 A decade of HIV\AID5 in Iran
M. Avijgan
Medital University ofShahre-kord, Iran
Setting: The first case of HIV/AIDS in Iran discovered in 1986.
Objective: The purpose ofstudy is an overview on epidemy ofHIV in Iran.
Methods: It used from the information published yearly by the ministry of
health.
Resuhs: The first case of HIV/AIDS in Iran was an haemophilic child. The
male to female ratio that was 7:1 earlier, changed to 27:1 later. The
predominant way of transmission in men, women, and overall is drug
abuse, sexual and drug abuse respectively. The difercnt gatcgoreis are as
follow: I-mother to child: 0/5% or 7 cases (4 cases imponed or Ir:mi:m
imigrants) and 3 indigenous cases that have been increased 3 fold. 2-
Unknown: 3/2% Or 46 cases (they might be infected by sexual contact. 3-
Blood products: 12/6% or 182 cases (170 haemophilic children and 12 cases
of blood recipients. (6 of them imponed»). The increase in this group is not
very significant. (167 cases in first year to 182 in 1998). 4-Drug abuse: 7 cases
in early epidemy have been increased to 989 cases or 68/5% (7 cases of them
imported). 5-sexual intercours: 15/2% or 219 cases; one HIV + prostitute
(among 6366 tested persons), 2 cases HIV + with STD (among 19254 tested
persons), 26 wives ofinfected (15 imported), 48 expelled iranian prostitutes,
3 international travellers, 3 international drivers and sailors, 7 overseas
resident in Iran, 145 HIV+ volunteers for testing (28 imported) among
51187 persons and 30 HIV + blood donors (5 imported) among 6408957
persons.
Conclusion: I-The changes ofpredominant way oftransmission from blood
to drug abuses. 2-Sexual contact is the main way of transmission in women.
3-lndigenous cases in prostitutes. drug abuses, volunteers and blood donors
indicating the top of ice berge. 4-lncreasing the confidentiality between
patients and official responsibles. 5-An increasing development of epidemy
will be expected by sexual way, in the case of no appropriate education for
high risk group.
IMoP171 HCV and HTLV-I/II among HIV-1 infected IDUs in
Moscow region. Russia
M. Bobkova l , N. Detkova·, T. Shoshnikova l , E. Buravtsova l , V.
Pokrovsky·. V. Bondarenk02, A. Bobkov2
'Russian AIDS Center; 2Ivanovsky Inst Virol, Moscow, Russian Federation
Objectives: Since the end of1996 the number ofHIV-1 infected individuals
in Russia has been increased more than tenfold with the majority of them
being rejecting drug users (IOUs). In 1999. new local IOUs outbreak of
HIV-I infection in Moscow and Moscow region was registered. Up to
December I, 1999, the total number of HIV-I cases in this region reached
6.510. The main goal of this sting was to investigate the prevalence ofHCV
and HTLV-I/II infections among HIV-infected IDUs in Moscow and
Moscow region.
Methods: The serum samples derived from HIV-1 infected IDUs in
Moscow and Moscow region (n = 458) were analysed for :mti-HTLV-I/
II antibodies (Serodia HTLV-I, Fujirebio, Japan and Genelabs HTLV 2.4
Western Blot, Singapore were used for screening and confirmation, respec-
tively). and for HCcAb (Organon Teknika, The Netherlands) and HCV
RNA [Okamoto H et al. JpnJ Exp Med. 1990,60: 215).
Results: Only 4 sera were reactive in the HTLV-1/11 screening assay :md all
were negative in the confirmatory assay. whereas 89.3% (409/458) and 68%
(17/25) of sera were positive for HccAb and HCV RNA, respectively. At
least 3 HCV genetic subtypes were found among the cohort studied, namely,
1b (706%.12/17), 2a (11.8%.2/17), and 3a (176%,3/17).
Condusions: There is still no evidence of HTLV V-I/II infection in the
Russian IDUs populations. The variety of HCV genetic subtypes found in
this cohon indicate that this virus was introduced into the IDUs population
in Moscow region by multiple sources.
IMoP181 Particularities of hepatitis B Infection at children HIV
positive
V. Lazureanu, V. Musta, D. Stanescu, E. Nicoara, N. Nicolescu, T. Moisil
University OfMedicine and PharmlUology Timisoara, Romania
Introduction: Hepatitis virus B infection is often associated with HIV
infection at children in Romania, because of its common way of transmis-
sion.
Objective: The study intended to analyze the clinico-biological parameters
of hepatitis B infection associated HIV infection.
Method: We made a statistical :malyze of56 children hospitalized in Clinical
Hospital of Infectious Disease "V. Babes" Timisoara between 1990-1999.
All of them presented an association between HIV infection and Hepatitis B
infection.
Resuhs: The majority of this children were born between 1988-1990.
Most of them were boys and had an urban origin.
The predominant clinical manifestations were hepatomegaly and spleno-
megaly.
The liver biological tests did not revealed severe forms of the disease.
24 patients were treated with antiretroviral therapy for HIV infection and
had no specific drags for hepatitis B infection.
6 patients died.
Conduslons: The horizontal transmission of HIV infection at children in
Romania is a particularity that associate very frecqent this infection with
hepatitis B infection.
Virus B hepatitis had no severe forms in association with HIV infection.
The association of the two infections had a negative influence on HIV
infection evolution.
IMoP191 HBV and HCV markers among HIV infected patients
in R. Macedonia
V. Grunevska, LJ. Ivanovski, D. Dimitriev, S. Sami, M. Gaseva. C.
Nasteska, B. Sain. K. Grozdanovski
Clinic of Infectious Diseases, "Ss. Cyril and Methodius" University, Skopje,
FYROM
Objectives: To investigate HBV and HCV infections among HIV infected
persons in Macedonia because of their identical transmission model.
Material and Methods: This is a prospective study ofHIV infected penons
tested for HBV and HCV infections (1987-2000). The main criterion for
HIV testing was the risk ofinfection verified by epidemiological methods or
clinical manifestations. Persons were grouped by sex. age, nationality, and
risk for infection. Antibodies for HIV were tested with Enzygnost Anti HIV
l Plus, Lia Tek HIV I + 2, ABBOT Recombinant HIV l3rd generation
EIA, and confirmed using HIV 1 Western Blot Kit, and Chiron RIBA HIV
I/HIV 2 SIA. HBV and HCV infections were tested by Enzygnost HBsAg
monoclonal II, Enzygnost HBe monoclonal. Enzygnost Anti HBs II. Onho
HCV 3.0 ELISA, ABBOT HCV EIA 2nd Generation. and UBI HCY EIA
4.0. Positive serums for HCV antibodies were retested by ELISA kits from
different manufacturers for result reliability.
Resuhs: Out of 52 verified HIV infected citizens of Macedonia, 35 were
tested for HBV and HCV infections. In 4 (11.4%) patients. antibodies for
HCV were detected. 11 (31.4%) were HBsAg and 8 (22.9%) anti HBs
positive, making 19 (54.3%) with present or past HBV infection. Co-
infection with HCV and HBsAg was identified in 1 Haemophilia patient. 1
drug user and 1 person with risky sexual contacts. 12 (34.4%) of 35
investigated HIV positive persons were without markers for HCV and
HBV.
Conclusions: The presence of markers for HBV and HCV in HIV infected
patients is intensive compared to the general population, where the pre-
valence is 1.4% for HBV and 1.2% for HCY. All of these infections are
associated with liver damage in HIV infected persons with clinical and
epidemiological consequences.
IMoP20ICorrelation among viral load and HAART in a cohort
of HIV patients
L. Clericol • L. Cosentino·, G. Placid02, P. Faziil • G. Riario Sfonal
,Departme", ofClinical Microbiology, "Spirito Santo" Hospital, P"scara;
2Department of Infectious Diseases, "Spirito Santo" Hospital, Pescara, Italy
Introduction: Advances have been made in the understanding of the
pathogf."nesis of HIV inff."ction and in tr""tment and monitoring of HIV
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disease since 1994. Moreover HAART leads to a profund and sustained
suppression of viral replication with a rise in CD4 + cells count.
Patients and method: We made a cohort study on 32 HIV infected patients:
they made a two years therapy with nucleoside R T inhibitor, nonnucleoside
R T inhibitor and protease inhibitor. We classified the patients according to
the criteria of CDC at the start of therapy: we had 17 (53.12%) patients at
stage A, 6 (18.75%) patients at stage B, 9 (28.12%) at stage C. We considered
the number ofCD4+ cells (Epics-XL-MCL Coulter) and viral load (HIV-l
test version 1.5 ROCHE). We performed the follow-up of the patients at 3-
6-12-18-24 months.
Results and: discussion Seventy-one percent ofpatients at stage A had a viral
load < 400 copies/mL (694 cells/mm3CD4 +, mean value) after 24 months
oftheraPr. 33% ofpatients at stage B had a viral load < 400 copies/mL (328
cells/mm CD4+, mean value). 22% ofpatients at stage Chada viral load <
400 copies/mL (311 cells/mm CD4 + , mean value).
The early initiation ofaggressive combination therapy suppresses the viral
replication and preserve the immune function, as in our cases
P:1/3 - Opportunistic and bacterial infections in HIV
IMoP21! HIV + tuberculosis dual epidemic developernent at
North-West of Russia
A. Vasyliev, Graschenkova, E. Savine
Research Inst. ofPhthysiopulmonology, St.-Petersburg, Russiall Federation
Objectives: To investigate the dynamic of HIV and TB epidemic at the
population of Kalyningrad region.
Methods: Retrospective study was conducted. Cases ofTB and HIV were
analysed for the period 1991-1999.
Results: The firsts two cases of HIV detected before 1991 were analysed by
E. Savine et al. (1992). One of them was imported from Cote d'Ivoire, the
source ofthe other is still unknown Since 1996 is observing the rapid increase
in HIV. At the beginning of 1999 the number of cases has reached 2809
(297.8/100.000). 64.4% of HIV-infected persons were drug users, 2.3%-
children. Sexual transmission was estimated in 13.2%. The incidence ofTB
increases steadily since 1991 (34.7/100.000). By the end of1998 the rate 87.6/
100.000 was reported. The morbidity rate in children waS highest (126.2/
100.(00). In 1996 has begun the registration ofHIV + TB cases: 1996 -10,
1997 - 16, 1998 - 29 patients.
Conclusions: New phase in the development of epidemic of HIV and TB
(dual epidemic) has begun in 1996 at Kalyningrad region. It can be predicted
that in short period there would be dramatic growth in HIV + TB.
Tuberculosis would be most frequent opportunistic infection.
IMoP22! Relationship between HPV and other STD agents In
concomitant cervicitis among HIV posltive women
M. Cupic, A. Knezevic, 0]. Jevtovicl ,]. Ranin l , T. Jovanovic, M. Bujk02
IlIStitute ofMicrobiology and Immunology, School of Medicille, Ulliversityof
Belgrade; I Cetltre for HIV/AIDS, Institute for illfeetiolls alld tropical diseases
"Dr Kosta Todorovic", UKC, Belgrade; 2Institlltefor PIIbUc Health,
Ulliversity ofMotltetlegro, Podgorica, Yugoslavia
Presence ofetiological various genital pathogens on the cervix, represent the
major risk factors for concomitant cervicitis among HIV positive women.
The aim of this study was to investigate the presence of Humatl papilloma
virus (HPV), Chlamydia trachomatis (CT), Mycoplasma homillis (MH), Urea-
plasma urealyticum (UU), Herpes simplex virus (HSV) type 1 and 2 and
Cytomegalovirus (CMV) on the cervix uteri of29 HIV positive women.
The presence ofHPV in cervical smears was diagnosed with HPV-DNA
in situ hybridization test; CT and HSV type 1 and 2 were detected by the test
of direct immunofluorescence; CMV by the test of indirect immunofluor-
escence and genital mycoplasmas (MH, UU) were detected by colorimetric
methode.
The results showed that 9 of29 HIV positive women were HPV positive;
all ofthem had one or more then one STD agent detected in cervical.mca....
Six of9 HIV positive patients had concomitant cervicitis caused by: CT and
HPV (2/9), CT, HSV type 2 and HPV (2/9) and CMV and HPV (2/9). The
other 3 HIV positive women had UU and HPV (1/9). CMV, UU and HPV
(1/9) and CT, UU and HPV (1/9).
HPV associated with other STD agents as cofactors are frequent cause of
concomitant cervicitis among HIV positive women. These agents also have
an important role in the development of cervical dysplasia and cancer, so
their detection will improve the prevention and control of oportunistic
infections among HIV positive women.
lMoP~ A case-control study of herpes zoster following
highly active antiretroviral therapy (HAART)
P. Domingo', O. H. Torres,]. M. Guardiola,]. Ris, M. Gurgui, G.
Vazquez
Hospital de la Sallta Creu i Sant Pall, Barcelona, Spain
Background: Initiation ofhighly active antirerroviral therapy is followed by
unwelcome inflammatory reactions causing distinct clinical syndromes. The
use of these agents may be associated with unforeseen effects not previously
observed.
Methods: Twelve HIV-infected patients with baseline CD4 lymphocyte
counts ofless than 500 cells/ttL were treated because of herpes zoster (HZ)
within 17 weeks starting protease-inhibitor therapy. The control group were
48 HIV-infected patients matched by age, sex, baseline plasma HIV-1 RNA
and CD4 cell count, and length of follow-up. A historical control group
consisting of 12 HIV-infected patients who had HZ before the use of
protease inhibitors was also used for comparison.
Results: Cases of HZ associated with protease-inhibitor therapy were less
severe than historic controls. The incidence of HZ associated to protease-
inhibitor therapy was 8.90 episodes per 100 patient-years. There were
statistically significant differences between patients and controls in the
increase ofthe number ofCD8 cells, both in absolute number and percentage
(p = 0.0004 and p = 0.0001, respectively), while there were no differences
between CD4 counts and plasma HIV-l RNA. In the multivariate analysis
the only clinical circumstance that independently predicted appearance of
HZ was the increase in percentage ofCD8 cells (OR: 1.33; 95% CI: 1.14-
1.54, P = 0.00(2).
Condusions: Initiation ofHIV-I protease-inhibitor therapy in patients with
CD4 cell counts of less than 500 celis/ttL was associated with an increased
incidence ofherpes zoster. No factors predicting a higher risk for developing
clinically evident HZ could be identified in the present study except for a
higher increase in the percentage ofCD8 cells before its appearance.
IMoP24ICryptosporidlosis In HIV infected patients In Western
Poland




tDept. of Illf Diseases; 2Dept. ofBiology alld Med. Parasitology Univ. ofMed.
SciellleS, POZllall, Polalld; Div. ofParasitic Diseases, CDC, Atlanta, Georgia,
Ullited States
objectives: Evaluation of frequency of the cryptosporidiosis in HIV -
positive patients (pts)
Methods: Forty HIV infected patients (9 F, 31 M, aged x = 34.2 ± 10.2 ys)
were examined for presence of Cryptosporidiosis. Ten of them had
periodically diarrhoeas in history. Risk behaviors in this group were:
homosexual men - 11 pts (27.5%), IVDU - 16 pts (40%), heterosexual -
13 pts (32.5%). Lymphocytes CD4 mean level was 236 ± 188 c/mm3. Stage
ofinfection (CDC 93): category A -20 pts (50%), B - 7 pIS (17.5%), C -13
pts (32.5%). Coinfection with HBV was detected in4 pts (10%), HCV in 17
pIS (42.5%), CMV in 7 pts (17.5%). Probable duration ofHIV infection was
x = 7.5 ± 3.3 ys.
Stool specimens were examined for the detection ofoocysts, coproantigen
(ProSpecT Cryptosporidium Microplate Assay) and DNA od Cryptospor-
idium (PCR).
Results: The presence ofCryptosporidium was detected in 10 patiens (25%).
OOCYSIS, coproantigen and DNA of this parasite was identified soley in one
specimen (F, IVDU, 19 ys), while Cryptosporidium DNA was detected in 8
specimens (6 M: 2 IVDU, 4 homosexual; 2 F: IVDU and heterosexual; aged
29-58 ys, x = 38.4 ± 10.5 ys). Cryptosporidium coproanrigen was found
ouly in one >ample (M, homosexual, 41 ys). There was no difference berween
pts from Crypto (+) and Crypto (-) groups in age, gender, CDC stage,
CD4 count and coinfection with hepatotropic viruses. Crypto (+) pts had
longer duration ofHIV infection than Crypto (-) pIS (p < 0.05). Three of
Crypto (+) pts died within 6 months. Only two Crypto (+) pts had
diarrhoeas which were treated symptomaticly with success.
